Journals Slow to Retract Slutsky Research Errors

SAN DIEGO-Three U.S. journals still have not published retractions or clarifications on nine articles by Robert A. Slutsky that 18 months ago were declared fraudulent or questionable. One small journal is waiting for its publishing house to obtain permission from Slutsky. A second publication has withdrawn only research retracted by Slutsky himself. The third journal has printed no corrections because neither Slutsky nor his co-authors have requested retractions. All said they feared litigat

Written byRex Dalton
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

SAN DIEGO-Three U.S. journals still have not published retractions or clarifications on nine articles by Robert A. Slutsky that 18 months ago were declared fraudulent or questionable.

One small journal is waiting for its publishing house to obtain permission from Slutsky. A second publication has withdrawn only research retracted by Slutsky himself. The third journal has printed no corrections because neither Slutsky nor his co-authors have requested retractions. All said they feared litigation by offended co-authors.

At least 11 scientific journals have printed retractions for most of the 48 questioned and 12 fraudulent articles Slutsky wrote. And many of the journals that published his valid research have reaffirmed the integrity of those articles.

In 1984 the University of California-San Diego concluded that Slutsky, a radiology trainee, had produced 60 research papers in which the data were fraudulent or questionable. The work involved dozens of colleagues, many of whom had been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies